// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

The effects of exercise and physical activity in inflammatory rheumatic diseases: a scoping literature review

Raj Amarnani - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

N/A

Stress matters: inflammatory arthritis patients' perspective of impact of stress

Clare Jacklin - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

Results of a consensus process to determine the elements of a complex digital intervention for distal upper limb musculoskeletal disorders

Lucy Brading - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Exercise as an anti-inflammatory treatment in axial spondyloarthritis (axSpA): a proof-of-concept study

Matthew Roberts - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Axial spondyloarthritis

N/A

Significant functional impairment and disability in individuals with psoriatic arthritis and Achilles tendon pain

Aimie Patience - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Dermatology

Psoriatic arthritis

N/A

Comparative effectiveness of different exercise interventions on central sensitisation indices in humans: A systematic review and network meta-analysis

Aya A Abd Elkhabir - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Intra-articular platelet-rich plasma injections versus intra-articular corticosteroid injections for the symptomatic management of knee osteoarthritis: a systematic review and meta-analysis

Michael E D McLarnon - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Knee osteoarthritis

N/A

Mendelian randomization studies of lifestyle-related risk factors for osteoarthritis: a PRISMA review and meta-analysis

Justin Ho - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

Beyond articular cartilage: a systematic review of the extracellular matrix in other components of the osteoarthritic joint

Jolet Y Mimpen - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Bone mineral density predicts fractures when measured in more than one area: results from a large observational cohort

Ummaz Nadeem - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Bone health in men with prostate cancer on androgen deprivation therapy: audit and service development

Ziyan Sheng - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Prostate cancer

Androgen Tear

Use of an electronic text messaging service to improve efficiency in initial Fracture Liaison Service Patient Assessment

Rosie Reid - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Hydroxyzine

Print and online news representations of osteoporosis and its treatment in the UK: a framing analysis

Rosie Turner - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoporosis

N/A

Is it necessary to test vitamin D prior to zoledronate or denosumab treatment?

James Keasley - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoporosis

Zolendronic acid

Research priorities regarding the use of bisphosphonates for osteoporosis: a UK priority setting exercise

Zoe Paskins - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoporosis

N/A

How are beliefs about osteoporosis medicines elicited and addressed in clinical consultations: a video observational study

Ashley W Hawarden - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoporosis

N/A

The relationship between self-reported adherence, drug levels and tumour necrosis factor inhibitor response in psoriatic arthritis

Philippa D K Curry - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Dermatology

Psoriatic arthritis

Adalimumab

First ever Juvenile Idiopathic Arthritis Awareness Week

Debbie Wilson - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Service evaluation of ultrasound use in patients with juvenile idiopathic arthritis in a UK tertiary paediatric rheumatology centre, as the first step towards developing an evidence-based guideline

Lucy A Stead - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

New2JIA Right Start Service from JIA-at-NRAS

Debbie Wilson - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved